Vaccine response against SARS-CoV-2 in patients with primary Sjögren's syndrome
Latest Information Update: 21 Dec 2022
At a glance
- Drugs Ad26.COV2 S (Primary) ; AZD 1222 (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Pharmacodynamics
- Acronyms VaccineSS
- 19 Dec 2022 Status changed from recruiting to completed.
- 28 Apr 2021 New trial record